Premenstrual Syndrome (PMS) involves a range of physical and emotional symptoms in the 1–2 weeks before menstruation that resolve once the period begins. Symptoms are real and uncomfortable but generally manageable and do not significantly impair daily functioning.

Premenstrual Dysphoric Disorder (PMDD) is a far more severe form that significantly disrupts daily life, relationships, and work. PMDD is classified as a depressive disorder in the DSM-5 and requires formal medical diagnosis and treatment. The distinction matters because PMDD responds specifically to targeted treatments that are not typically needed for PMS.

The most common PMDD symptoms include severe mood swings, intense irritability or anger, feelings of hopelessness or depression, anxiety and tension, difficulty concentrating, fatigue, disturbed sleep, food cravings or binge eating, breast tenderness, and bloating.

For a formal PMDD diagnosis, at least 5 of these symptoms must be present in the premenstrual week and must improve within a few days of the period starting. Symptoms must also be severe enough to interfere with work, relationships, or daily activities. The cyclical nature — onset in the luteal phase, resolution after menstruation — is the defining diagnostic feature.

The exact cause of PMDD is not fully understood, but current evidence strongly suggests it is caused by an abnormal sensitivity to the normal hormonal fluctuations of the menstrual cycle — particularly changes in oestrogen and progesterone during the luteal phase. These hormonal shifts are thought to dysregulate serotonin and other neurotransmitter systems in the brain that control mood.

Importantly, women with PMDD do not necessarily have abnormal hormone levels — rather, their brains appear to respond differently to normal hormonal changes. Genetic factors play a role: PMDD runs in families. A personal or family history of depression, anxiety, trauma, or PTSD also increases risk. Stress and lifestyle factors may worsen symptom severity but are not primary causes.

PMDD is diagnosed by a healthcare provider based on symptom history — there is no blood test for PMDD. Your doctor will typically ask you to track your symptoms daily over at least two menstrual cycles using a validated tool such as the Daily Record of Severity of Problems (DRSP).

Diagnosis follows criteria from the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition), which requires at least 5 specific symptoms that: (1) appear primarily in the luteal phase, (2) resolve within a few days of menstruation, and (3) are severe enough to substantially interfere with daily functioning. Your doctor will also rule out other conditions such as thyroid disorders, major depressive disorder, and generalised anxiety disorder that may mimic or overlap with PMDD.

PMDD has several effective treatment options. First-line treatment is SSRIs (selective serotonin reuptake inhibitors) such as fluoxetine, sertraline, or paroxetine, taken either continuously every day or intermittently during the luteal phase only. Both strategies produce rapid, significant symptom relief for most women.

Second-line options include hormonal therapies such as the combined oral contraceptive pill containing drospirenone (e.g. Yaz/Yasmin) or GnRH agonists that suppress ovulation. Cognitive Behavioural Therapy (CBT) is an effective adjunct, particularly for mood symptoms. Lifestyle measures — regular exercise, dietary changes, and stress reduction — complement medical treatment. A personalised combination approach, guided by a healthcare provider, is typically most effective.

There is no permanent cure for PMDD in the traditional sense, but symptoms can be very effectively managed with the right treatment plan. Many women experience substantial improvement with SSRIs, hormonal therapy, or a combination of both alongside lifestyle strategies. Quality of life can be significantly restored.

PMDD symptoms naturally cease at menopause, when cyclical hormonal changes stop. Some women also experience remission during pregnancy. Regular follow-up with a healthcare provider is important, as treatment needs may change over time — particularly during perimenopause, when hormonal fluctuations can intensify.

See a doctor if your symptoms are severe enough to interfere with your work, relationships, or daily activities; if you experience intense feelings of hopelessness, despair, or suicidal thoughts (seek emergency help immediately in that case); or if over-the-counter remedies and lifestyle changes have not helped after two or more cycles.

PMDD is a recognised medical condition — you do not need to endure it without support. Early diagnosis and treatment can dramatically improve quality of life. Tracking your symptoms for two cycles before your appointment (using a diary or the DRSP tool) will help your doctor make an accurate diagnosis.

PMDD is classified in the DSM-5 as a depressive disorder, but it is biologically and clinically distinct from major depressive disorder (MDD) or generalised anxiety disorder. The critical difference is cyclicity: PMDD symptoms appear specifically in the luteal phase and improve significantly — often completely — once menstruation begins.

Outside the premenstrual window, most women with PMDD feel relatively well. This on-off pattern directly tied to the menstrual cycle is what distinguishes PMDD from persistent depression, where symptoms are continuous. That said, PMDD can co-exist with depression and anxiety, and a thorough evaluation by a healthcare provider is important to ensure all conditions are correctly identified and treated.

Yes — lifestyle changes have meaningful evidence for reducing PMS symptoms and can complement medical treatment for PMDD. Regular aerobic exercise (at least 30 minutes, most days) is one of the most consistently supported interventions, reducing both physical and mood-related symptoms through endorphin release and serotonin support.

Dietary adjustments also help: reducing caffeine, alcohol, refined sugar, and salt (particularly in the premenstrual phase), eating small and frequent meals to stabilise blood sugar, and increasing calcium and magnesium-rich foods. Stress management practices such as yoga, mindfulness, and cognitive techniques can reduce symptom reactivity. Tracking symptoms monthly helps you anticipate difficult days and plan accordingly. While lifestyle measures rarely eliminate PMDD on their own, they are a valuable part of a holistic treatment plan.

The first-line pharmacological treatment for PMDD is SSRIs (selective serotonin reuptake inhibitors) — specifically fluoxetine, sertraline, or paroxetine. These can be taken continuously (every day) or intermittently (luteal phase only, typically days 14–28 of the cycle). Both approaches are effective, with intermittent dosing often preferred to minimise side effects.

Second-line options include the combined oral contraceptive pill containing drospirenone, GnRH agonists (for severe cases), and transdermal oestrogen. Additional medications for specific symptoms include spironolactone (for bloating and fluid retention), buspirone (for anxiety), and NSAIDs (for pain). In rare, treatment-resistant cases, surgical removal of the ovaries may be considered. All treatment decisions should be made with a qualified healthcare provider.

PMDD affects approximately 3–8% of women of reproductive age who meet strict DSM-5 diagnostic criteria. A further 13–18% may experience dysphoric premenstrual symptoms severe enough to cause significant distress and functional impairment without meeting the full diagnostic threshold. PMS affects up to 75% of menstruating people to some degree.

Despite its prevalence, PMDD is frequently underdiagnosed. Symptoms are often dismissed as "normal hormones," misdiagnosed as generalised depression or anxiety, or go unreported due to stigma around menstrual health and mental illness. Greater clinical awareness and patient advocacy are essential to improve diagnosis rates and access to treatment.

PMDD does not necessarily worsen in a linear way with age, but many women report their symptoms intensify in their late 30s and 40s as perimenopause approaches and hormonal fluctuations become more pronounced and irregular. The perimenopausal transition can temporarily amplify PMDD severity for some women. PMDD symptoms typically resolve at menopause, when cyclical ovarian hormonal changes cease entirely. If symptoms worsen significantly at any age, it is important to discuss this with a healthcare provider, as treatment adjustments may be needed.

Yes. PMDD can significantly impact relationships due to the cyclical pattern of severe mood symptoms — including intense irritability, anger, emotional withdrawal, and outbursts — that characterise the premenstrual phase. Partners, family members, and colleagues may find the predictable but intense monthly pattern difficult to understand or navigate without context. With proper diagnosis, treatment, and communication, many women and their partners see a substantial improvement in relationship quality. Psychoeducation for partners and, in some cases, couples therapy can also be beneficial alongside individual treatment.

Yes. Women with PMDD have a higher likelihood of co-existing anxiety disorders, major depression, and a history of trauma or PTSD. PMDD can also significantly worsen the symptoms of underlying mood disorders during the luteal phase, a phenomenon sometimes called "premenstrual magnification." This makes accurate diagnosis important: a thorough mental health and hormonal evaluation is needed to ensure that all co-existing conditions are identified, not just PMDD in isolation. Treating PMDD often improves co-existing mental health symptoms as well.

No single diet cures PMDD, but evidence supports several dietary strategies for reducing symptom severity. Calcium has the strongest evidence among nutritional supplements for PMS and PMDD — studies suggest 1,000–1,200 mg of calcium daily can reduce mood and physical symptoms. Magnesium supplementation may also help reduce bloating, mood disturbances, and headaches.

Reducing caffeine, alcohol, refined sugar, and salt — particularly in the week before menstruation — can meaningfully ease symptoms. Eating small, regular meals rich in complex carbohydrates helps stabilise blood sugar and may reduce mood swings. Foods high in omega-3 fatty acids (oily fish, flaxseed) and tryptophan (turkey, eggs, dairy) support serotonin production. A nutrient-dense, anti-inflammatory diet is a valuable complement to medical treatment, though it should not replace it for PMDD.